Richard Buka

@richardbuka.bsky.social

Haem reg interested in thrombosis. Chair of HaemSTAR. Father of 3. Founder of pathquestionbank.com Blog: http://classicalcompass.substack.com. Pod: Don't Just Read the Abstract

The latest episode of Don't Just Read the Abstract with is now up! We discuss the APPOINT-PNH trial of ictacopan, a proximal complement inhibitor and the first oral therapy for PNH. Available now on all podcast platforms.

Bild

Abstract submission for #ISTH2025 is OPEN! Tag someone who should definitely submit an abstract below⏬

Thomas Reiser@tomreiser.bsky.social · 2y ago

Abstract Submission for the #ISTH2025 Congress is now Open. Deadline is January 15, 2025! Don't miss showcasing your most exciting research and contribute to advancing the understanding of #thrombosis and #hemostasis on a global scale! https://buff.ly/3B2XFQy @ISTH-official.bsky.social #HemeSky

Tons of NEW DATA about andexanet, presented as part of FDA hearing last week. If you couldn’t make it through the short 6h meeting, GOOD NEWS, I’ve watched it and highlighted the important points. A🧵

Bild

Recent Danish study of 569k individuals presented at AHA scientific sessions found poor oral health in children to be associated with increased risk of ischemic heart disease, myocardial infarction, and ischemic stroke in adulthood. Just one more reason that fluoride in our water is a good idea.

Very much enjoying my first couple of days on Bsky! Lovely interface and healthy interactions. Social media for the good of humanity rather than profit or some other nefarious goal. Still on X for the moment but will post on both. The switching moat is wide and deep!

1/ FDA hearing on #andexanet alfa is tomorrow (21 Nov 2024). The documents contain some more data on thrombotic events that weren't published in ANNEXA-I. To be honest, reading through, I have found this data pretty shocking. A 🧵

Bild